01 / RESEARCH SUMMARY
Semaglutide Research Summary
Semaglutide is a GLP-1 receptor agonist. It increases glucose-dependent insulin release, slows gastric emptying and reduces appetite through signaling in the brain. It is FDA-approved as Ozempic and Rybelsus for type 2 diabetes and as Wegovy for weight management. In the STEP 1 trial, 2.4 mg weekly produced about 14.9% mean weight loss over 68 weeks, and the SELECT trial showed a 20% reduction in major cardiovascular events in people with obesity and heart disease. Its roughly 7-day half-life supports once-weekly dosing.
Read the full guide →02 / WHY RESEARCHERS STUDY IT
Why Semaglutide draws research interest
These are the areas researchers and the peptide community explore Semaglutide for most often. They describe what is being studied — not proven benefits, approved uses, or promised results.
Weight management
FDA-approved as Wegovy; STEP trials showed about 15% average weight loss.
Type 2 diabetes
Lowers blood sugar and HbA1c through GLP-1 signaling (Ozempic, Rybelsus).
Heart health
The SELECT trial showed 20% fewer major cardiovascular events.
Liver & kidney
Studied in fatty liver disease (MASH) and diabetic kidney disease.
Evidence ranges from early lab work to large clinical trials depending on the use — see the sections below for the data and sources.
03 / DOSING & RECONSTITUTION
Dosing & Reconstitution Guide
A single practical dilution with accurate dosing, step by step
Standard Approach (1 mL = 10 mg/mL)
- Reconstitute: Add 1 mL bacteriostatic water to one 10 mg vial → final concentration 10 mg/mL (10,000 mcg/mL).
- Typical range: 0.25–2.4 mg 1x daily · 1–2x weekly (split dose), As long as needed.
- Easy measuring: At 10 mg/mL, 1 unit ≈ 100 mcg on a U-100 syringe, so doses read at 2.5–24 units — a 0.3 mL (30-unit) syringe makes them easier to read.
- Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.
| Protocol | Dose range | Frequency | Cycle | Time off | Half-life | Fasted | Route |
|---|---|---|---|---|---|---|---|
| Injectable · Subq | 0.25–2.4 mg | 1x daily · 1–2x weekly (split dose) | As long as needed | As needed | ~7 days | No | Subq |
| Obesity · STEP 1 (2021) | 2.4 mg | Once weekly | 68 weeks | Subcutaneous (study formulation) |
04 / RECONSTITUTION CALCULATOR
Mix & measure Semaglutide · 10 mg
Pre-filled with this protocol's recommended BAC water and starting dose — edit any field to run your own numbers.
- CONCENTRATION
- 10.00 mg/mL
- DRAW VOLUME
- 0.025 mL
- ON THE SYRINGE
- 2.5 units
- DOSES / VIAL
- 40
Reconstitution math only. U-100 syringe: 100 units = 1 mL.
Reconstitution GuideFull calculator →05 / STORAGE
Storage Instructions
Lyophilized (powder)
Store in the freezer at −20 °C (−4 °F) for long-term storage, or refrigerated at 2–8 °C for shorter periods. Keep dry, sealed and away from light. Let a frozen vial reach room temperature before opening to avoid condensation.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 28 days. Do not freeze. Keep away from heat and direct light, and avoid repeated temperature swings. Swirl gently — never shake.
Reconstitution steps
- Wipe the vial stopper with an alcohol swab.
- Draw the BAC water and release it slowly down the inside wall of the vial.
- Swirl or roll gently until fully dissolved — don't shake.
- Label with the date and concentration and refrigerate.
06 / RESEARCH FINDINGS
What Research Shows
Human research
- STEP 1 evaluated body-weight reduction in adults with overweight or obesity without diabetes.
- Licensed semaglutide medicines have indication-specific evidence for weight management and type 2 diabetes; injectable and oral formulations have different labeling.
Research context
The community-provided 1G-SGT mapping does not independently verify the vendor vial's identity, sterility, or equivalence to Wegovy or Ozempic.
07 / MOLECULAR BIOLOGY
Mechanism of Action
Characterized biological pathway
GLP-1 receptor
Activates GLP-1 receptors, increasing glucose-dependent insulin secretion and reducing glucagon secretion. Effects on appetite and gastric emptying contribute to its metabolic actions.
Adamantane & the blood–brain barrier
Chemically attaching an adamantane group to a peptide can increase its lipid (fat) solubility. Researchers hypothesize that this modification may help certain compounds cross the tightly regulated blood–brain barrier. The effect depends on the specific modified molecule; greater lipid solubility alone does not establish brain delivery or clinical benefit. This does not apply automatically to the unmodified peptide and is not a reconstitution additive.
08 / LIFESTYLE FACTORS
Lifestyle Factors
- Protein: aim for adequate protein (about 0.7–1 g per lb of goal body weight) to preserve muscle during weight loss.
- Resistance training: lift 2–4x per week to protect lean mass.
- Hydration & fiber: drink plenty of water and eat fiber to reduce constipation and nausea.
- Meal size: eat smaller meals and stop at fullness; greasy, heavy meals worsen GI side effects.
- Titrate slowly: stay at a dose until side effects settle before increasing.
09 / BENEFITS & SIDE EFFECTS
Potential Benefits & Side Effects
Potential Benefits
- Significant reduction in appetite and food noise
- Clinically meaningful weight loss
- Improved blood sugar and insulin sensitivity
- Improvements in blood pressure, lipids and liver fat
Side Effects
- Nausea, vomiting, diarrhea or constipation (most common, usually during dose increases)
- Reduced appetite to the point of under-eating
- Fatigue and occasional headache
- Increased heart rate (especially triple/glucagon agonists)
- Rare: gallbladder problems or pancreatitis — seek care for severe abdominal pain
10 / STUDIES
Studies & references
11 / SAFETY
Safety considerations
- Verify the active identity, lot number, and matching certificate of analysis. Testing does not by itself establish sterility or suitability for human use.
- Follow documented product-specific storage and preparation requirements; stability and diluent compatibility depend on the formulation.
- Research powders are not interchangeable with prescription formulations. Do not infer an injection or nasal protocol from a concentration calculation.
- For medical care, pregnancy, existing conditions, or medication interactions, consult a qualified healthcare professional.
12 / RECOMMENDED SOURCE
Recommended Source
For research peptides, we point researchers to Orbitrex Peptides for Semaglutide.
Why Orbitrex?
- Family-owned & independently tested: Multiple laboratories verify quality, with batch-specific testing in every COA.
- Everyday value: Buy 4, Get 1 Free on eligible products.
- Loyalty credit: 5% back in loyalty credit for future purchases.
- VerifyPass discount: 20% off for qualifying groups — stacks with affiliate codes.
- Free 2nd Day shipping: Free UPS 2nd Day Air on orders $200+, applied automatically at checkout.
All products are for research use only. Availability and offers subject to change.